BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10645226)

  • 1. Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases.
    Korshunov A; Golanov A; Sycheva R; Pronin I
    J Clin Pathol; 1999 Aug; 52(8):574-80. PubMed ID: 10645226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical markers for prognosis of cerebral glioblastomas.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):217-36. PubMed ID: 12187957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.
    Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic importance of cancer-associated proteins and apoptosis in glioblastomas of the cerebral hemispheres].
    Korshunov AG; Golanov AV; Sycheva RV; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 1999; (1):3-7. PubMed ID: 10335568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
    Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
    Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis.
    Ribeiro Mde C; Coutinho LM; Hilbig A
    Arq Neuropsiquiatr; 2004 Jun; 62(2A):262-70. PubMed ID: 15235729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
    Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
    Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.
    Soini Y; Virkajärvi N; Lehto VP; Pääkkö P
    Br J Cancer; 1996 May; 73(9):1025-30. PubMed ID: 8624258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of p53 protein expression in glioblastoma.
    Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA
    Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
    Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K
    Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of apoptosis and proliferation in germinoma and glioblastoma.
    Mizoguchi M; Inamura T; Shono T; Ikezaki K; Inoha S; Ohgami S; Fukui M
    Neuro Oncol; 2000 Apr; 2(2):96-102. PubMed ID: 11303626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
    de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
    Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
    J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
    Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
    J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Johannessen AC; Liavaag PG; Nilsen R; Vasstrand EN
    Oral Oncol; 1999 May; 35(3):302-13. PubMed ID: 10621852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
    Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma.
    Berker B; Dunder I; Ensari A; Cengiz SD; Simsek E
    Eur J Gynaecol Oncol; 2002; 23(6):505-10. PubMed ID: 12556092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.